Disease Domain | Count |
---|---|
Nervous System Diseases | 4 |
Neoplasms | 1 |
Top 5 Drug Type | Count |
---|---|
Herbal medicine | 5 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date27 May 2019 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date01 Jan 1996 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date01 Jan 1992 |
Start Date07 May 2020 |
Sponsor / Collaborator |
Start Date28 Mar 2014 |
Sponsor / Collaborator |
Start Date17 Nov 2013 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
DuLiang Pills | Headache More | Approved |
Shendan Huoxue Capsule | Female Genital Neoplasms More | Approved |
AnGongNiuHuang | Cerebral Hemorrhage More | Approved |
Wuling San | Edema More | Approved |
Qingnao Xuanqiao Dropping Pills | Stroke More | Phase 3 |